Injectable Anesthetic Sensorcaine Recalled for Subpotent Epinephrine
Sensorcaine injectable anesthetic is being recalled because testing showed the epinephrine component is below the required potency level. No illnesses or injuries have been reported.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a subpotent drug where the epinephrine concentration is below required limits. No illnesses or injuries have been reported, but the defect represents a risk of harm if inadequate potency compromises anesthetic effectiveness.
Plain-English summary
Sensorcaine (bupivacaine hydrochloride and epinephrine injection, USP) is a prescription injectable anesthetic with a vasconstrictor component. Fresenius Kabi USA is recalling 40,375 vials distributed nationwide, specifically 50 mL multiple-dose vials (NDC 63323-461-01).
Testing results indicated that the epinephrine portion of this product is below the defined potency limit, making it subpotent. Affected batches are: Batch #6128061 (expiring March 2024) and Batches #6128663 and #6128664 (expiring May 2024).
No illnesses or injuries have been reported. Healthcare providers should check their inventory for the affected batch numbers and discontinue use of any recalled product.
The recalled product
- Product
- SENSORCAINE (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE)
- Brand
- SENSORCAINE
- Manufacturer
- Fresenius Kabi USA, LLC
- Category
- Drug — Injectable Anesthetic
- Hazard
- Affected units
- 40,375
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Batch #: 6128061
- exp 03/2024
- 6128663
- 6128664
- exp 05/2024
UPCs (6)
- 0363323472030
- 0363323461010
- 0363323463014
- 0363323468026
- 0363323472016
- 0363323468019
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 3 recalled by Fresenius Kabi USA, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 3 products in this recall →Related recalls
Same brand · SENSORCAINE
- HighPrescription Anesthetic Drug Recalled for Subpotent Epinephrine Content
FDA (Drugs) · 2023-01-25
- HighLocal anesthetic Sensorcaine vials recalled for subpotent epinephrine
FDA (Drugs) · 2023-01-25
- ModerateFresenius Kabi Recalls Sensorcaine Due to Low Epinephrine Levels
FDA (Drugs) · 2020-12-30
- SevereFresenius Kabi Recalls Sensorcaine Due to Glass Particulate Matter
FDA (Drugs) · 2016-06-22
Same manufacturer · Fresenius Kabi USA, LLC
See all →- SevereFresenius Kabi Recalls Tyenne Injection Due to Glass Particles
FDA (Drugs) · 2026-09-02
- CriticalFresenius Kabi Recalls Morphine Syringes Due to Labeling Error
FDA (Drugs) · 2026-08-26
- HighXylocaine Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateGlycopyrrolate Injection Recall Due to Hair Contamination
FDA (Drugs) · 2026-07-29
- ModerateFDA Recalls Xylocaine Injections Due to Hair Contamination
FDA (Drugs) · 2026-07-29
Same hazard · subpotent
See all →- ModerateCAREone Earwax Removal Drops Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
- HighCompounded vasopressin syringes recalled as subpotent by IntegraDose Compounding Services
FDA (Drugs) · 2026-06-24
- ModerateSkin Rehab calming hydrocortisone balm recalled as a subpotent drug
FDA (Drugs) · 2026-04-22
- Moderateglo Skin Beauty Remedy Gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22
- ModerateRhonda Allison calming skin gel recalled as a subpotent hydrocortisone product
FDA (Drugs) · 2026-04-22